{"nct_id":"NCT01227889","title":"A Study Comparing GSK2118436 to Dacarbazine (DTIC) in Previously Untreated Subjects With BRAF Mutation Positive Advanced (Stage III) or Metastatic (Stage IV) Melanoma","status":"COMPLETED","status_verified_date":"2017-08","start_date":"2010-12-23","start_date_type":"ACTUAL","primary_completion_date":"2011-12-19","primary_completion_date_type":"ACTUAL","completion_date":"2016-09-16","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}